Results 191 to 200 of about 7,778 (203)
Some of the next articles are maybe not open access.
Blood, 2015
Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent and add a burden on families in Egypt and Middle East due to lifelong diet restriction. Non-fava beans diet is the main food for most families in the region and parents and doctors consider it as a prohibited food whatever the genetic or
Mohsen Saleh ElAlfy
exaly +2 more sources
Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent and add a burden on families in Egypt and Middle East due to lifelong diet restriction. Non-fava beans diet is the main food for most families in the region and parents and doctors consider it as a prohibited food whatever the genetic or
Mohsen Saleh ElAlfy
exaly +2 more sources
IntroductionGlucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked hereditary disorder in southern China. However, the incidence rate of G6PD deficiency and the frequency of the most common G6PD gene variants vary widely. The purpose of this study was to investigate the prevalence, genotype, and phenotypic features of G6PD deficiency ...
Jinfu Zhou +10 more
exaly +4 more sources
British Journal of Haematology, 2005
SummaryGlucose‐6‐phosphate dehydrogenase (G6PD) deficient individuals are at increased risk of developing haemolysis following treatment with various antimalarial drugs. Reliable field tests for G6PD deficiency are thus needed in chemotherapy studies and their validity has to be assessed.
Peter E, Meissner +9 more
openaire +2 more sources
SummaryGlucose‐6‐phosphate dehydrogenase (G6PD) deficient individuals are at increased risk of developing haemolysis following treatment with various antimalarial drugs. Reliable field tests for G6PD deficiency are thus needed in chemotherapy studies and their validity has to be assessed.
Peter E, Meissner +9 more
openaire +2 more sources
2017
Primaquine is the only drug licensed for prevention of relapse in vivax and ovale malarias. It causes mild to severe hemolysis when administered to patients with G6PD deficiency. Because current methods for identifying these patients are not well-suited to care in malaria endemic areas like those in Indonesia, most patients do not receive anti-relapse ...
openaire +1 more source
Primaquine is the only drug licensed for prevention of relapse in vivax and ovale malarias. It causes mild to severe hemolysis when administered to patients with G6PD deficiency. Because current methods for identifying these patients are not well-suited to care in malaria endemic areas like those in Indonesia, most patients do not receive anti-relapse ...
openaire +1 more source

